AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27263997 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking independently at 30 months
Number of subjects: 183
Study 27263997 — intervention group
Group type: EXPERIMENTAL
Intervention: Family resources at 12 months
Number of subjects: 183
Study 25335123 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Epoetin beta (30,000 IU on days 1, 2, and 3)
Number of subjects: 16
Study 25335123 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose Epoetin beta (5000 IU on days 1, 3, 5, 7, 9, 11, and 13)
Number of subjects: 16
Study 25335123 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 23532835 — intervention group
Group type: EXPERIMENTAL
Intervention: Existential behavioural therapy (EBT)
Number of subjects: 160
Study 23532835 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (control group)
Number of subjects: 160
Study 20006168 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (300 microg)
Number of subjects: 0
Study 20006168 — intervention group
Group type: COMPARATOR
Intervention: Blood transfusion (fresh frozen plasma 10 mL/kg and/or 1 unit of single donor platelets)
Number of subjects: 0
Study 20006168 — intervention group
Group type: COMPARATOR
Intervention: Blood transfusion
Number of subjects: 0
Study 20006168 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin
Number of subjects: 0
Study 18715755 — intervention group
Group type: EXPERIMENTAL
Intervention: NET+VOC
Number of subjects: 72
Study 18715755 — intervention group
Group type: COMPARATOR
Intervention: VOC only
Number of subjects: 72
Study 16632019 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fludrocortisone (0.1 mg/d; n = 18)
Number of subjects: 37
Study 16632019 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control; n = 19)
Number of subjects: 37
Study 16632019 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludrocortisone and control groups
Number of subjects: 37
Study 12955758 — intervention group
Group type: EXPERIMENTAL
Intervention: Static magnetic field (SMF) combined with antineoplastic chemotherapy
Number of subjects: 0
Study 12955758 — intervention group
Group type: COMPARATOR
Intervention: Historical control subjects
Number of subjects: 0
Study 10998482 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-apheresis (LA) with concomitant simvastatin administration
Number of subjects: 20
Study 8987046 — intervention group
Group type: EXPERIMENTAL
Intervention: Median nerve SEPs
Number of subjects: 27
Study 8987046 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibial nerve SEPs
Number of subjects: 27
Study 8987046 — intervention group
Group type: COMPARATOR
Intervention: MRI abnormalities
Number of subjects: 27
Study 8987046 — intervention group
Group type: COMPARATOR
Intervention: Clinical presentation
Number of subjects: 27
Study 1619204 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein beverage
Number of subjects: 10
Study 1619204 — intervention group
Group type: COMPARATOR
Intervention: Cow's milk
Number of subjects: 10
Study 6321073 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymostimulin (TS)
Number of subjects: 21
Study 6321073 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 21
Study 30153382 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine sodium oral solution (4 × 150-μg unit-dose ampules) with water
Number of subjects: 36
Study 30153382 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine sodium oral solution (4 × 150-μg unit-dose ampules) without water
Number of subjects: 36
Study 30153382 — intervention group
Group type: COMPARATOR
Intervention: Levothyroxine sodium soft capsule (4 × 150-μg capsules) with water
Number of subjects: 36
Study 30161153 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture (n = 12)
Number of subjects: 25
Study 30161153 — intervention group
Group type: COMPARATOR
Intervention: Sham laser acupuncture (n = 13)
Number of subjects: 25
Study 30161153 — intervention group
Group type: COMPARATOR
Intervention: Verum acupuncture and Sham laser acupuncture
Number of subjects: 25
Study 27155071 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based problem-solving guided self-help intervention
Number of subjects: 0
Study 27155071 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 0
Study 25265768 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine 2.5 mg and atropine 1.2 mg
Number of subjects: 51
Study 25265768 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 2.5 mg, glycopyrrolate 0.2 mg and atropine 0.6 mg
Number of subjects: 51
Study 22459700 — intervention group
Group type: EXPERIMENTAL
Intervention: Active radiation treatment (890-nm wavelength, 6 sessions of 40 minutes each)
Number of subjects: 72
Study 22459700 — intervention group
Group type: COMPARATOR
Intervention: Placebo radiation treatment
Number of subjects: 72
Study 22459700 — intervention group
Group type: EXPERIMENTAL
Intervention: Active radiation treatment (890-nm wavelength)
Number of subjects: 72
Study 20064223 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment with sulphadoxine-pyrimethamine (SP) implemented in 11 health sub-districts.
Number of subjects: 1350
Study 20064223 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-intervention zone) with no IPTi.
Number of subjects: 1350
Study 18684703 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline
Number of subjects: 133
Study 18684703 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 133
Study 18684703 — intervention group
Group type: COMPARATOR
Intervention: Linezolid
Number of subjects: 133
Study 15853199 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzydamine rinse
Number of subjects: 32
Study 15853199 — intervention group
Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 32
Study 12638102 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 integral
Number of subjects: 40
Study 12638102 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 integral
Number of subjects: 40
Study 12638102 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 wedge
Number of subjects: 40
Study 12638102 — intervention group
Group type: EXPERIMENTAL
Intervention: burst
Number of subjects: 40
Study 11025955 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-nitrous oxide anesthesia (Group P)
Number of subjects: 28
Study 11025955 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane-nitrous oxide anesthesia (Group I)
Number of subjects: 28
Study 11025955 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group P and Group I)
Number of subjects: 28
Study 9118819 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexfenfluramine 15mg twice daily with dietary support
Number of subjects: 0
Study 9118819 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexfenfluramine
Number of subjects: 0
Study 1396480 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran concentrate (11.2 g of beta-glucan daily)
Number of subjects: 0
Study 1396480 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 3889933 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (800 IU/day)
Number of subjects: 30
Study 3889933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 29502092 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest drainage (tube thoracostomy)
Number of subjects: 0
Study 29502092 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 0
Study 25549202 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus nasogastric feeding
Number of subjects: 12
Study 25549202 — intervention group
Group type: COMPARATOR
Intervention: Continuous nasogastric feeding
Number of subjects: 12
Study 24910929 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time biofeedback
Number of subjects: 20
Study 24910929 — intervention group
Group type: COMPARATOR
Intervention: Mirror feedback
Number of subjects: 20
Study 24910929 — intervention group
Group type: COMPARATOR
Intervention: Raw video feedback
Number of subjects: 20
Study 24910929 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 20
Study 22365875 — intervention group
Group type: EXPERIMENTAL
Intervention: Senior resident directed (group B)
Number of subjects: 120
Study 22365875 — intervention group
Group type: COMPARATOR
Intervention: Attending directed (group A)
Number of subjects: 120
Study 19523615 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS patients undergoing controlled ovarian stimulation
Number of subjects: 80
Study 19523615 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-PCOS women)
Number of subjects: 80
Study 18314197 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection drug users (IDUs)
Number of subjects: 430
Study 18314197 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection drug users (IDUs) without endocarditis
Number of subjects: 430
Study 18314197 — intervention group
Group type: COMPARATOR
Intervention: Nonaddicts
Number of subjects: 430
Study 15735072 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular margarine (high PHVO)
Number of subjects: 12
Study 15735072 — intervention group
Group type: COMPARATOR
Intervention: Low TFA margarine (low PHVO)
Number of subjects: 12
Study 15735072 — intervention group
Group type: COMPARATOR
Intervention: Butter (low PHVO but high in naturally occurring TFA)
Number of subjects: 12
Study 12633131 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline transdermal system (STS), 20 mg/20 cm², daily for up to 8 weeks
Number of subjects: 289
Study 12633131 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 289
Study 11862376 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol (hydrocortisone 20 mg)
Number of subjects: 14
Study 11862376 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 10207191 — intervention group
Group type: EXPERIMENTAL
Intervention: Carisolv method (gel treatment)
Number of subjects: 137
Study 10207191 — intervention group
Group type: COMPARATOR
Intervention: Traditional drilling
Number of subjects: 137
Study 7605811 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ionic contrast medium (Meglium-Ioglicinat, Imeprol)
Number of subjects: 50
Study 7605811 — intervention group
Group type: COMPARATOR
Intervention: Ionic contrast medium
Number of subjects: 50
Study 2189417 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg/day of ciamexon
Number of subjects: 21
Study 2189417 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/day of ciamexon
Number of subjects: 21
Study 2189417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 2189417 — intervention group
Group type: EXPERIMENTAL
Intervention: ciamexon (both dosages)
Number of subjects: 21
Study 219802 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen therapy (large doses of oral conjugated estrogen for three months)
Number of subjects: 40
Study 219802 — intervention group
Group type: COMPARATOR
Intervention: Placebo (administered for a comparable period)
Number of subjects: 40
Study 6341417 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol-Hydrochlorothiazide combination
Number of subjects: 70
Study 6341417 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol alone
Number of subjects: 70
Study 6341417 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide alone
Number of subjects: 70
Study 31593327 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise three times a week on a stationary bike
Number of subjects: 47
Study 30502985 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 parts per million denatonium benzoate in sterile water (n = 14)
Number of subjects: 28
Study 30502985 — intervention group
Group type: COMPARATOR
Intervention: Sterile water only (n = 14)
Number of subjects: 28
Study 26795132 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized active physiotherapy starting 2 weeks after surgery (n=12)
Number of subjects: 25
Study 26795132 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmuscular surgical procedure (n=12)
Number of subjects: 25
Study 26795132 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=13)
Number of subjects: 25
Study 26795132 — intervention group
Group type: EXPERIMENTAL
Intervention: Paramedian surgical procedure (n=13)
Number of subjects: 25
Study 23623825 — intervention group
Group type: EXPERIMENTAL
Intervention: A/T neurofeedback
Number of subjects: 33
Study 23623825 — intervention group
Group type: EXPERIMENTAL
Intervention: SMR training
Number of subjects: 33
Study 23623825 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention controls
Number of subjects: 33
Study 22723573 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriflunomide 7 mg once daily
Number of subjects: 1088
Study 22723573 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriflunomide 14 mg once daily
Number of subjects: 1088
Study 22723573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1088
Study 20465142 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week NutriActive program
Number of subjects: 70
Study 20465142 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study 19119703 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic Disease Management (DM)
Number of subjects: 902
Study 19119703 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented Disease Management (ADM; DM plus in-home visits by a respiratory therapist)
Number of subjects: 902
Study 19119703 — intervention group
Group type: COMPARATOR
Intervention: Traditional Care
Number of subjects: 902
Study 16120150 — intervention group
Group type: EXPERIMENTAL
Intervention: 595-nm PDL (pulse width 1.5 ms)
Number of subjects: 18
Study 16120150 — intervention group
Group type: EXPERIMENTAL
Intervention: 595-nm PDL (pulse width 1.5 ms and 6 ms)
Number of subjects: 18
Study 16120150 — intervention group
Group type: EXPERIMENTAL
Intervention: 595-nm PDL (pulse width 20 ms)
Number of subjects: 18
Study 12636956 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin vaginal cream
Number of subjects: 409
Study 12636956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 409
Study 12636956 — intervention group
Group type: COMPARATOR
Intervention: Term infants
Number of subjects: 409
Study 10789597 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral granisetron
Number of subjects: 51
Study 10789597 — intervention group
Group type: COMPARATOR
Intervention: i.v. granisetron
Number of subjects: 51
Study 8849763 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal letter signed by GP with a pre‐fixed appointment
Number of subjects: 1170
Study 8849763 — intervention group
Group type: EXPERIMENTAL
Intervention: Same as A + letter supporting the study by a well known scientist
Number of subjects: 1170
Study 8849763 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter signed by the study coordinator
Number of subjects: 1170
Study 8849763 — intervention group
Group type: EXPERIMENTAL
Intervention: One enema, self administered at home two hours before the test
Number of subjects: 1170
Study 8849763 — intervention group
Group type: EXPERIMENTAL
Intervention: Two enemas, administered the night before and two hours before the test
Number of subjects: 1170
Study 1378141 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg once daily
Number of subjects: 14
Study 1378141 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine sustained-release 20 mg twice daily
Number of subjects: 14
Study 1378141 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment of carvedilol and nifedipine SR
Number of subjects: 14
Study 1378141 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy (either carvedilol or nifedipine SR)
Number of subjects: 14
Study 6383098 — intervention group
Group type: EXPERIMENTAL
Intervention: Revisional gastroplasty (gastrogastrostomy)
Number of subjects: 122
Study 6383098 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversion to Roux-Y gastric bypass
Number of subjects: 122
Study 6383098 — intervention group
Group type: COMPARATOR
Intervention: Primary gastric bypass
Number of subjects: 122
Study 31310575 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine intervention
Number of subjects: 240
Study 31310575 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 240
Study 31310575 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine intervention (post hoc analysis)
Number of subjects: 240
Study 31310575 — intervention group
Group type: COMPARATOR
Intervention: Control group (post hoc analysis)
Number of subjects: 240
Study 30030308 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led medication review
Number of subjects: 157
Study 30030308 — intervention group
Group type: COMPARATOR
Intervention: Control (no pharmacist-led medication review)
Number of subjects: 157
Study 26838248 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth-rinse with G-CSF (150-300ug plus 100ml-500ml normal saline) for at least 7 days
Number of subjects: 14
Study 26838248 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth-rinse with G-CSF
Number of subjects: 14
Study 24733157 — intervention group
Group type: EXPERIMENTAL
Intervention: Acromioplasty
Number of subjects: 95
Study 24733157 — intervention group
Group type: COMPARATOR
Intervention: Nonacromioplasty
Number of subjects: 95
Study 22532515 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid 5 mg intravenous once yearly
Number of subjects: 7736
Study 22532515 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7736
Study 20796312 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 4310
Study 20796312 — intervention group
Group type: COMPARATOR
Intervention: Comparator regimens
Number of subjects: 4310
Study 18554876 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia patients
Number of subjects: 9
Study 18554876 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 9
Study 16026360 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 3700
Study 16026360 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 3700
Study 16026360 — intervention group
Group type: EXPERIMENTAL
Intervention: Gliclazide
Number of subjects: 3700
Study 12296617 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg/day
Number of subjects: 3127
Study 12296617 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 8 mg/day
Number of subjects: 3127
Study 12296617 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3127
Study 9893190 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled albuterol dry powder 1600 microg
Number of subjects: 10
Study 9893190 — intervention group
Group type: COMPARATOR
Intervention: Inhaled placebo
Number of subjects: 10
Study 9893190 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled albuterol dry powder after placebo pretreatment
Number of subjects: 10
Study 8873523 — intervention group
Group type: EXPERIMENTAL
Intervention: #1 PDS suture placed in a continuous fashion
Number of subjects: 229
Study 8873523 — intervention group
Group type: COMPARATOR
Intervention: #1 Ethibond suture placed using an interrupted figure‐eight technique
Number of subjects: 229
Study 1675877 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (n = 9)
Number of subjects: 19
Study 1675877 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 10)
Number of subjects: 19
Study 6891608 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 alpha‐androst‐16‐en‐3 alpha‐ol (androstenol)
Number of subjects: 0
Study 6891608 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29283670 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered home-based health coaching intervention over 20 weeks
Number of subjects: 325
Study 29283670 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 325
Study 29283670 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based health coaching intervention
Number of subjects: 325
Study 27130812 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers who perceived it easy to remember medication names
Number of subjects: 141
Study 27130812 — intervention group
Group type: COMPARATOR
Intervention: Caregivers who did not easily remember medication names
Number of subjects: 141
Study 25563879 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg)
Number of subjects: 152
Study 25563879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 24908910 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer Group
Number of subjects: 24
Study 24908910 — intervention group
Group type: EXPERIMENTAL
Intervention: DVD Group
Number of subjects: 24
Study 24908910 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer + DVD Group
Number of subjects: 24
Study 24908910 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 24
Study 20562295 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mM theophylline
Number of subjects: 6
Study 20562295 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mM L-NAME
Number of subjects: 6
Study 20562295 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined 4 mM theophylline + 10 mM L-NAME
Number of subjects: 6
Study 20562295 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer solution (control)
Number of subjects: 6
Study 18589032 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-only group (caloric intake reduced by 2,800 kcal/week)
Number of subjects: 0
Study 18589032 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (caloric intake reduced by 2,400 kcal/week and expended approximately 400 kcal/week through aerobic exercise)
Number of subjects: 0
Study 18589032 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dietary protein intake (0.62 g/kg body weight/day)
Number of subjects: 0
Study 16025960 — intervention group
Group type: COMPARATOR
Intervention: Drug-therapy plus acupuncture (Group B)
Number of subjects: 0
Study 16025960 — intervention group
Group type: COMPARATOR
Intervention: Drug-therapy plus ETSM and acupuncture (Group C)
Number of subjects: 0
Study 16025960 — intervention group
Group type: COMPARATOR
Intervention: Drug-therapy only (Group A)
Number of subjects: 0
Study 12849771 — intervention group
Group type: EXPERIMENTAL
Intervention: Double cue inhibition of return (IOR) procedure
Number of subjects: 4